RxDoctor Payments Data

Margaret Horner, APRN

Family · Edmond, OKNPI 1689195703

Payments from drug & device makers

$1,899in general payments, 2019–2025

Across 117 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$390
  • AbbVie$222
  • Novo Nordisk$184
  • Corium, LLC$181
  • GSK$146
  • Lilly USA, LLC$115
  • plus $660 from 22 others

What the payments were for

  • Food & beverage$1,899100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,899 in reported general payments places this provider in the 80th percentile of 2,026 family providers in Oklahoma.

See all family providers in Oklahoma

Medicare billing

Part B allowed, 2024
$33,389
Medicare patients
171
Services billed
419

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$27,303
LinzessLinaclotide11$6,955
Rosuvastatin Calcium61$1,501
Losartan Potassium60$776
Omeprazole41$732
Albuterol Sulfate HfaAlbuterol Sulfate22$504
Amlodipine Besylate59$484
Levothyroxine Sodium51$455
Fluticasone Propionate20$434
Escitalopram Oxalate19$336
Azelastine Hcl12$307
Gabapentin21$300
Atorvastatin Calcium33$299
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide11$267
Pravastatin Sodium16$231

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$184$27,30315 claims
AbbVieLinzess$222$6,95511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,026 family providers in Oklahoma.

Other family in Edmond

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →